| 臺大學術典藏 |
2020-09-30T08:49:22Z |
Relationship between body mass index, antidiabetic agents, and midterm mortality in patients with both type 2 diabetes mellitus and acute coronary syndrome
|
Wu C.-C.; Hwang J.-J.; Chang K.-C.; Su F.-Y.; Chen K.-C.; Yin W.-H.; Chan S.-H.; YEN-WEN WU; Wang K.-Y.; Hsieh M.-Y.; Pan S.-L.; Li H.-Y.; Jong C.-B. |
| 臺大學術典藏 |
2020-09-30T08:49:20Z |
Impact of type D personality on clinical outcomes in Asian patients with stable coronary artery disease
|
Leu H.-B.; Yin W.-H.; Tseng W.-K.; YEN-WEN WU; Lin T.-H.; Yeh H.-I.; Cheng Chang K.; Wang J.-H.; Wu C.-C.; Chen J.-W. |
| 臺大學術典藏 |
2020-09-30T08:49:19Z |
2019 focused update of the guidelines of the Taiwan society of cardiology for the diagnosis and treatment of heart failure
|
Wang C.-C.; Wu C.-K.; Tsai M.-L.; Lee C.-M.; Huang W.-C.; Chou H.-H.; Huang J.-L.; Chi N.-H.; Yen H.-W.; Tzeng B.-H.; Chang W.-T.; Chang H.-Y.; Wang C.-H.; Lu Y.-Y.; Tsai J.-P.; Su C.-H.; Cherng W.-J.; Yin W.-H.; Tsai C.-T.; YEN-WEN WU; Lin J.-L.; Hwang J.-J. |
| 臺大學術典藏 |
2020-09-30T08:49:18Z |
Circulating TNFSF14 (Tumor Necrosis Factor Superfamily 14) Predicts Clinical Outcome in Patients with Stable Coronary Artery Disease
|
Yin W.-H.; Wu C.-C.; Lin S.-J.; Chen J.-W.; Hsu C.-Y.; Tseng W.-K.; YEN-WEN WU; Lin T.-H.; Yeh H.-I.; Chang K.-C.; Wang J.-H.; Chou R.-H.; Huang C.-Y.; Huang P.-H.; Leu H.-B. |
| 臺大學術典藏 |
2020-09-30T08:49:16Z |
Circulating fatty-acid binding-protein 4 levels predict CV events in patients after coronary interventions
|
Chen J.-W.; Yeh H.-I.; National Taiwan Biosignature Research Investigators; Tsai H.-Y.; YEN-WEN WU; Tseng W.-K.; Leu H.-B.; Yin W.-H.; Lin T.-H.; Chang K.-C.; Wang J.-H.; Yeh H.-I.; Wu C.-C. |
| 臺大學術典藏 |
2020-09-30T08:49:16Z |
Author Correction: The prognostic significance of heart-type fatty acid binding protein in patients with stable coronary heart disease (Scientific Reports, (2018), 8, 1, (14410), 10.1038/s41598-018-32210-x)
|
Wang J.-H.; Chang K.-C.; Lin T.-H.; Leu H.-B.; Yin W.-H.; Tseng W.-K.; YEN-WEN WU; Ho S.-K.; Yeh H.-I.; Wu C.-C.; Chen J.-W. |
| 臺大學術典藏 |
2020-09-30T08:49:16Z |
The benefit of secondary prevention with oat fiber in reducing future cardiovascular event among CAD patients after coronary intervention
|
Wu J.-R.; Leu H.-B.; Yin W.-H.; Tseng W.-K.; YEN-WEN WU; Lin T.-H.; Yeh H.-I.; Chang K.-C.; Wang J.-H.; Wu C.-C.; Chen J.-W. |
| 臺大學術典藏 |
2020-09-30T08:49:13Z |
Association of Arachidonic Acid-derived Lipid Mediators with Subsequent Onset of Acute Myocardial Infarction in Patients with Coronary Artery Disease
|
Huang C.-C.; Chang M.-T.; Leu H.-B.; Yin W.-H.; Tseng W.-K.; YEN-WEN WU; Lin T.-H.; Yeh H.-I.; Chang K.-C.; Wang J.-H.; Wu C.-C.; Shyur L.-F.; Chen J.-W. |
| 臺大學術典藏 |
2020-09-30T08:49:13Z |
Potential impacts of high-sensitivity creatine kinase-MB on long-term clinical outcomes in patients with stable coronary heart disease
|
YEN-WEN WU; Ho S.K.; Tseng W.-K.; Yeh H.-I.; Leu H.-B.; Yin W.-H.; Lin T.-H.; Chang K.-C.; Wang J.-H.; Wu C.-C.; Chen J.-W. |
| 臺大學術典藏 |
2020-09-30T08:49:13Z |
2020 consensus of taiwan society of cardiology on the pharmacological management of patients with type 2 diabetes and cardiovascular diseases
|
Li Y.-H.; Liu P.-Y.; Chang K.-C.; Shyu K.-G.; Huang J.-L.; Tsai C.-D.; Hung H.-F.; Liu M.-E.; Chao T.-F.; Cheng S.-M.; Cheng H.-M.; Chu P.-H.; Yin W.-H.; YEN-WEN WU; Chen W.-J.; Lai W.-T.; Lin S.-J.; Yeh S.-J.; Hwang J.-J.; Chiang C.-E.; Ueng K.-C.; Chao T.-H.; Lin T.-H.; Wu Y.-J.; Wang K.-L.; Sung S.-H.; Yeh H.-I. |
| 臺大學術典藏 |
2020-06-01T06:31:24Z |
Relationship between body mass index, antidiabetic agents, and midterm mortality in patients with both type 2 diabetes mellitus and acute coronary syndrome
|
Jong C.-B.;Hung-Yuan Li;Pan S.-L.;Hsieh M.-Y.;Su F.-Y.;Chen K.-C.;Yin W.-H.;Chan S.-H.;Wu Y.-W.;Wang K.-Y.;Chang K.-C.;Hwang J.-J.;Wu C.-C.; Jong C.-B.; HUNG-YUAN LI; Pan S.-L.; Hsieh M.-Y.; Su F.-Y.; Chen K.-C.; Yin W.-H.; Chan S.-H.; Wu Y.-W.; Wang K.-Y.; Chang K.-C.; Hwang J.-J.; Wu C.-C. |
| 臺大學術典藏 |
2020-04-07T07:00:52Z |
Relationship between body mass index, antidiabetic agents, and midterm mortality in patients with both type 2 diabetes mellitus and acute coronary syndrome
|
Su F.-Y.; Chen K.-C.; Yin W.-H.; Chan S.-H.; Wu Y.-W.; Wang K.-Y.; Chang K.-C.; Hwang J.-J.; Wu C.-C.; SHIN-LIANG PAN; Hsieh M.-Y.; Li H.-Y.; Jong C.-B.; Jong C.-B.;Li H.-Y.;Shin-Liang Pan;Hsieh M.-Y.;Su F.-Y.;Chen K.-C.;Yin W.-H.;Chan S.-H.;Wu Y.-W.;Wang K.-Y.;Chang K.-C.;Hwang J.-J.;Wu C.-C. |
| 臺大學術典藏 |
2020-03-04T09:03:16Z |
The Effect of Surgical Weight Reduction on Left Ventricular Structure and Function in Severe Obesity
|
Hsuan C.-F.;Huang C.-K.;Lin J.-W.;Lin L.-C.;Lee T.-L.;Tai C.-M.;Yin W.-H.;Tseng W.-K.;Hsu K.-L.;Chau-Chung Wu; Hsuan C.-F.; Huang C.-K.; Lin J.-W.; Lin L.-C.; Lee T.-L.; Tai C.-M.; Yin W.-H.; Tseng W.-K.; Hsu K.-L.; CHAU-CHUNG WU |
| 臺大學術典藏 |
2020-03-04T09:03:13Z |
2012 Guidelines of the Taiwan Society of Cardiology (TSOC) for the diagnosis and treatment of heart failure
|
Wang C.-C.; Chen J.-H.; Yu W.-C.; Cheng J.-J.; Yin W.-H.; CHAU-CHUNG WU; Li A.-H.; Lin W.-S.; Chen P.-S.; Ueng K.-C.; Huang J.-L.; Tsai F.-C.; Wang C.-H.; Fu T.-C.; Liu M.-H.; Chen P.-R.; Pai H.-Y.; Cherng W.-J. |
| 臺大學術典藏 |
2020-03-04T09:03:12Z |
Registry of lipid control and the use of lipid-lowering drugs for secondary prevention of cardiovascular events in patients with established atherosclerotic disease in Taiwan: Rationality and methods
|
Yin W.-H.; CHAU-CHUNG WU; Chen J.-W. |
| 臺大學術典藏 |
2020-03-04T09:03:11Z |
Gender difference in statin intervention on blood lipid control among patients with coronary heart disease
|
Chen C.-Y.;Chuang S.-Y.;Fang C.-C.;Huang L.-C.;Hsieh I.-C.;Pan W.-H.;Yeh H.-I.;Chau-Chung Wu;Yin W.-H.;Chen J.-W.; Chen C.-Y.; Chuang S.-Y.; Fang C.-C.; Huang L.-C.; Hsieh I.-C.; Pan W.-H.; Yeh H.-I.; CHAU-CHUNG WU; Yin W.-H.; Chen J.-W. |
| 臺大學術典藏 |
2020-03-04T09:03:10Z |
Gender disparities in optimal lipid control among patients with coronary artery disease
|
Chen C.-Y.;Chuang S.-Y.;Fang C.-C.;Huang L.-C.;Hsieh I.-C.;Pan W.-H.;Yeh H.-I.;Chau-Chung Wu;Yin W.-H.;Chen J.-W.; Chen C.-Y.; Chuang S.-Y.; Fang C.-C.; Huang L.-C.; Hsieh I.-C.; Pan W.-H.; Yeh H.-I.; CHAU-CHUNG WU; Yin W.-H.; Chen J.-W. |
| 臺大學術典藏 |
2020-03-04T09:03:10Z |
Increased rosuvastatin dose versus concomitant fenofibrate and rosuvastatin therapy to achieve lipid goal in patients with diabetes or atherosclerosis with metabolic syndrome
|
Yin W.-H.; Chen J.-W.; Lee Y.-T.; CHAU-CHUNG WU; Tseng W.-K.; Chen Y.-P.;Chang K.-C.;Tseng W.-K.;Yin W.-H.;Chen J.-W.;Lee Y.-T.;Chau-Chung Wu; Chen Y.-P.; Chang K.-C. |
| 臺大學術典藏 |
2020-03-04T09:03:09Z |
The impact of chronic kidney disease on lipid management and goal attainment in patients with atherosclerosis diseases in Taiwan
|
Lin T.-H.;Chuang S.-Y.;Chu C.-Y.;Lee W.-H.;Hsu P.-C.;Su H.-M.;Li Y.-H.;Fang C.-C.;Wang K.-Y.;Tseng W.-K.;Li A.-H.;Ueng K.-C.;Hsieh I.-C.;Huang L.-C.;Wang C.-H.;Pan W.-H.;Yeh H.-I.;Chau-Chung Wu;Yin W.-H.;Chen J.-W.; Lin T.-H.; Chuang S.-Y.; Chu C.-Y.; Lee W.-H.; Hsu P.-C.; Su H.-M.; Li Y.-H.; Fang C.-C.; Wang K.-Y.; Tseng W.-K.; Li A.-H.; Ueng K.-C.; Hsieh I.-C.; Huang L.-C.; Wang C.-H.; Pan W.-H.; Yeh H.-I.; CHAU-CHUNG WU; Yin W.-H.; Chen J.-W. |
| 臺大學術典藏 |
2020-03-04T09:03:08Z |
Determinants for achieving the LDL-C target of lipid control for secondary prevention of cardiovascular events in Taiwan
|
Ho L.-T.; Yin W.-H.; Chuang S.-Y.; Tseng W.-K.; Wu Y.-W.; Hsieh I.-C.; Lin T.-H.; Li Y.-H.; Huang L.-C.; Wang K.-Y.; Ueng K.-C.; Fang C.-C.; Pan W.-H.; Yeh H.-I.; CHAU-CHUNG WU; Chen J.-W. |
| 臺大學術典藏 |
2020-03-04T09:03:07Z |
Combination with low-dose dextromethorphan improves the effect of amlodipine monotherapy in clinical hypertension a first-in-human, concept-proven, prospective, dose-escalation, multicenter study
|
Yin W.-H.; Chen P.; Yeh H.-I.; Wang K.-Y.; Hung Y.-J.; Tseng W.-K.; Wen M.-S.; Wu T.-C.; CHAU-CHUNG WU; Cheng S.-M.; Chen J.-W. |
| 臺大學術典藏 |
2020-03-04T09:03:07Z |
Guideline-adherent therapy in patients with cardiovascular diseases in Taiwan
|
Jeng J.-S.; Yin W.-H.; Huang C.-C.; Chuang S.-Y.; Yeh H.-I.; Fang C.-C.; Lin T.-H.; Wang K.-Y.; Tseng W.-K.; Huang L.-C.; Ueng K.-C.; Hsieh I.-C.; Li Y.-H.; Pan W.-H.; CHAU-CHUNG WU; Chen J.-W.; Taiwanese Secondary Prevention for Patients with AtheRosCLErotic Disease (T-SPARCLE) Registry Investigators |
| 臺大學術典藏 |
2020-03-04T09:03:06Z |
Identification of new biosignatures for clinical outcomes in stable coronary artery disease - The study protocol and initial observations of a prospective follow-up study in Taiwan
|
Leu H.-B.; Yin W.-H.; Tseng W.-K.; Wu Y.-W.; Lin T.-H.; Yeh H.-I.; Chang K.-C.; Wang J.-H.; CHAU-CHUNG WU; Chen J.-W. |
| 臺大學術典藏 |
2020-03-04T09:03:05Z |
Optimal achieved blood pressure for patients with stable coronary artery disease
|
Huang C.-C.; Leu H.-B.; Yin W.-H.; Tseng W.-K.; Wu Y.-W.; Lin T.-H.; Yeh H.-I.; Chang K.-C.; Wang J.-H.; CHAU-CHUNG WU; Chen J.-W. |
| 臺大學術典藏 |
2020-03-04T09:03:05Z |
Lipid lowering therapy in patients with atherosclerotic cardiovascular diseases: Which matters in the real world? Statin intensity or low-density lipoprotein cholesterol level? – Data from a multicenter registry cohort study in Taiwan
|
Yeh Y.-T.; Yin W.-H.; Tseng W.-K.; Lin F.-J.; Yeh H.-I.; Chen J.-W.; Wu Y.-W.; CHAU-CHUNG WU; Taiwanese Secondary Prevention for Patients with AtheRosCLErotic Disease (T-SPARCLE) Registry Investigators |
